| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
K. Angela Macfarlane is Director at RNXT. K. Angela Macfarlane's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $53K at current prices.
Net of sales, the RNXT filings show accumulation of 40,983 shares.
K. Angela Macfarlane has 8 Form 4 filings on record from October 2021 to October 2026, all as Director at RenovoRx (RNXT), 2021–2026.
The 9 reported transactions were 7 option or other derivative awards and 2 open-market purchases.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26, 2024 | RNXT Renovorx, Inc. | Director | Buy | 40,983 | $0.00 | - | New | +15.2% | +31.4% |